330 related articles for article (PubMed ID: 6601718)
41. Circulating immune complexes in systemic lupus erythematosus.
Cano PO; Jerry LM; Sladowski JP; Osterland CK
Clin Exp Immunol; 1977 Aug; 29(2):197-204. PubMed ID: 302768
[TBL] [Abstract][Full Text] [Related]
42. Circulating immune complexes in IgA deficiency.
Kwitko AO; McKenzie PE; Shearman DJ; Gormly AA; Woodroffe AJ
Clin Exp Immunol; 1979 Oct; 38(1):45-51. PubMed ID: 527254
[TBL] [Abstract][Full Text] [Related]
43. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
44. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
45. Immune complex-like activity associated with abnormal serum lipoproteins in systemic erythematosus.
Smith GW; Hannan SF; Scott PJ; Simpson IJ
Clin Exp Immunol; 1982 Apr; 48(1):8-16. PubMed ID: 6979451
[TBL] [Abstract][Full Text] [Related]
46. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
Kohro-Kawata J; Wener MH; Mannik M
J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
[TBL] [Abstract][Full Text] [Related]
47. Specific detection of circulating DNA:anti-DNA immune complexes in human systemic lupus erythematosus sera using murine monoclonal anti-DNA antibody.
Tron F; Letarte J; Roque-Antunes Barreira MC; Lesavre P
Clin Exp Immunol; 1982 Aug; 49(2):481-7. PubMed ID: 6982138
[TBL] [Abstract][Full Text] [Related]
48. Solid phase C1q microassay for the rapid detection of circulating immune complexes.
Orozco A; Contreras CE; Sánchez P; Meilijson O; Bianco NE
J Immunol Methods; 1983 Apr; 59(2):237-43. PubMed ID: 6341470
[TBL] [Abstract][Full Text] [Related]
49. [Determination of immune complex levels--with special reference to C1q and the anti-antibody method].
Kasukawa R
Rinsho Byori; 1986 Oct; Spec No 69():35-44. PubMed ID: 3543438
[No Abstract] [Full Text] [Related]
50. Association between circulating immune complexes and renal disease in New Zealand mice.
Nakai Y; Yoshida H; Maruyama N; Shirai T; Hamashima Y
Clin Exp Immunol; 1981 Feb; 43(2):240-5. PubMed ID: 6974065
[TBL] [Abstract][Full Text] [Related]
51. [Serial studies of serum immune complexes and complements in patients with glomerulonephritis].
Nakayama S; Koide H; Ohno J
Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):163-9. PubMed ID: 6611432
[No Abstract] [Full Text] [Related]
52. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
[TBL] [Abstract][Full Text] [Related]
53. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
Caillot G; Lamelin JP; Hartmann DJ; Ville G
Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
[TBL] [Abstract][Full Text] [Related]
54. Ability of complement to release systemic lupus erythematosus immune complexes from cell receptors.
Medof ME; Scarborough D; Miller G
Clin Exp Immunol; 1981 May; 44(2):416-25. PubMed ID: 7307341
[TBL] [Abstract][Full Text] [Related]
55. Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes.
Horsfall AC; Venables PJ; Mumford PA; Maini RN
Clin Exp Immunol; 1981 May; 44(2):405-15. PubMed ID: 6975676
[TBL] [Abstract][Full Text] [Related]
56. [C1q solid-phase radioimmunoassay for detection of circulating immune complexes in patients with systemic lupus erythematosus (author's transl)].
Sato M; Kasukawa R; Suzuki S; Kameda S; Yoshida T
Ryumachi; 1978 Mar; 18(2):97-103. PubMed ID: 307277
[No Abstract] [Full Text] [Related]
57. [Is the demonstration of immune complex useful in the activity assessment of chronic polyarthritis?].
Schlumpf U; Ernst R; Christen P; von Felten A; Böni A
Schweiz Med Wochenschr; 1984 Jan; 114(4):118-30. PubMed ID: 6367028
[TBL] [Abstract][Full Text] [Related]
58. C1q microtiter plate ELISA system for detecting circulating immune complexes and its application of testing the sera in neurological diseases.
Araga S; Irie H; Takahashi K
Jpn J Exp Med; 1984 Feb; 54(1):23-7. PubMed ID: 6384588
[TBL] [Abstract][Full Text] [Related]
59. [Use of the C1q binding assay in the analysis of immune complexes: personal experiences with its clinical use and future prospectives].
Corvetta A; Spaeth PJ; Panico F; Ghirelli PA; Orecchioni F; Danieli G
G Clin Med; 1983; 64(9-10):337-48. PubMed ID: 6198235
[No Abstract] [Full Text] [Related]
60. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
